Michael Swinford Buys 16,471 Shares of ReWalk Robotics Ltd. (NASDAQ:LFWD) Stock

ReWalk Robotics Ltd. (NASDAQ:LFWD) Director Michael Swinford acquired 16,471 shares of the company’s stock in a transaction that occurred on Wednesday, November 20th. The shares were bought at an average price of $1.84 per share, for a total transaction of $30,306.64. Following the completion of the acquisition, the director now owns 26,511 shares of the company’s stock, valued at $48,780.24. This trade represents a 164.05 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

ReWalk Robotics Trading Up 2.7 %

NASDAQ LFWD opened at $1.91 on Monday. The firm’s 50 day moving average is $2.61 and its 200-day moving average is $3.54. ReWalk Robotics Ltd. has a 12-month low of $1.70 and a 12-month high of $9.10.

ReWalk Robotics (NASDAQ:LFWD) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.08). ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. The business had revenue of $6.13 million during the quarter, compared to analyst estimates of $8.38 million. During the same quarter in the previous year, the firm posted ($0.56) earnings per share. As a group, research analysts predict that ReWalk Robotics Ltd. will post -1.78 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a “buy” rating and issued a $13.00 price target on shares of ReWalk Robotics in a research note on Wednesday, November 13th.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in ReWalk Robotics stock. Dimensional Fund Advisors LP acquired a new stake in ReWalk Robotics Ltd. (NASDAQ:LFWD) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned about 0.16% of ReWalk Robotics at the end of the most recent quarter. Hedge funds and other institutional investors own 26.76% of the company’s stock.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.